Etoposide is indicated in the management of: Refractory Testicular Tumors: Etoposide for Injection Concentrate may be used as combination therapy with other approved chemotherapeutic agents in patients with refractory testicular tumors who have already received appropriate surgical, chemotherapeutic and radiotherapeutic therapy.
Small Cell Lung Cancer: Etoposide for Injection Concentrate may be used in combination with other approved chemotherapeutic agents as first-line treatment in patients with small cell lung cancer.
Hodgkin's Disease: Malignant (non-Hodgkin's) lymphomas, especially of the histiocytic variety, acute non-lymphocytic leukemia.